Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation

Background: The pharmacological cardioversion of recent-onset atrial fibrillation (AF) is a challenge for the clinician. The aim of the study was to compare the efficacy, the safety, and the overall cost of intravenous (iv) administration of vernakalant, which is a relatively new atrial-selective an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hippokratia
Autores principales: Vogiatzis, I, Papavasiliou, E, Dapcevitch, I, Pittas, S, Koulouris, E
Formato: Artigo
Lenguaje:Inglês
Publicado: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239091/
https://ncbi.nlm.nih.gov/pubmed/30455558
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares